FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper

Autor:	David M. Gershenson, Gwynn Ison, Robert L. Coleman, Deborah K. Armstrong, Annie Ellis, Thomas J. Herzog, Amy E. McKee, Shenghui Tang, Peg Ford, Bradley J. Monk, Richard Pazdur, Ronald D. Alvarez, Julia A. Beaver, Sanjeeve Balasubramaniam, Geoffrey Kim
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Endpoint Determination MEDLINE Gynecologic oncology Carcinoma Ovarian Epithelial 03 medical and health sciences 0302 clinical medicine White paper Internal medicine Carcinoma medicine Humans 030212 general & internal medicine Neoplasms Glandular and Epithelial Patient Reported Outcome Measures Ovarian Neoplasms Clinical Trials as Topic business.industry United States Food and Drug Administration Obstetrics and Gynecology medicine.disease United States Clinical trial 030220 oncology & carcinogenesis Female business Ovarian cancer
Zdroj:	Gynecologic oncology. 147(1)
ISSN:	1095-6859
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ba573a7ef7133615e1c7aa2d16e930 https://pubmed.ncbi.nlm.nih.gov/28844539 Zobrazit plný text záznamu Full Text from ScienceDirect